MedTrace Logo

Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment

NCT05261256 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-12-05

No results posted yet for this study

Summary

This study aims at investigating the feasibility of recruitment and application of a method regarding early detection of subclinical changes in cardiac health after completion of acute cancer treatment during childhood and adolescence.

Conditions

Interventions

DIAGNOSTIC_TEST

Exercise stress echocardiography

Study participants perform an exercise stress echocardiography on a semi-supine bicycle ergometer using using a continuous incremental bicycle protocol with a work rate increment every 3 minutes according to gender and weight.

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Renate Oberhoffer-Fritz, Prof. Dr. med. · Institute of Preventive Pediatrics, Department of Sport and Health Sciences, TUM

Eligibility

Min Age
10 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2024-10-31
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05261256 on ClinicalTrials.gov